New GLP-1 alternative, eloralintide, leads to 20% weight loss in trial

New GLP-1 alternative, eloralintide, leads to 20% weight loss in trial

Share on PinterestA new weight loss drug, eloralintide, has shown promise in Phase 2 trials. Catherine…

Continue Reading
Once-promising anti-inflammatory drug fails to improve long-COVID functional outcomes in trial

Once-promising anti-inflammatory drug fails to improve long-COVID functional outcomes in trial

Frerieke / Flickr cc A randomized clinical trial finds that the anti-inflammatory drug colchicine, once thought…

Continue Reading
Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment

Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment

Daly, B. et al. Misery Loves Company: Presenting Symptom Clusters to Urgent Care by Patients Receiving…

Continue Reading